Infec Dis Drug/Vacc Ed
Abstract
This project funds development of candidate medical countermeasures for militarily relevant infectious diseases. These products fall within four major areas: vaccines, drugs, diagnostic kits/devices, and determining if insects are infected with pathogenic organisms capable of infecting service members' insect control/preventive medicine measures to limit exposure and disease transmission. It funds research that supports conclusive human clinical trials for large-scale human effectiveness (capacity to produce a desired size of an effect under ideal or optimal conditions) testing, expanded human safety clinical trials, long-term animal studies, and related manufacturing tests. This work, which is jointly performed by military laboratories, civilian contracted pharmaceutical firms and foreign research partners, is directed toward the prevention of disease, early diagnosis, and speeding recovery once diagnosed. Medical products approved for human use must successfully complete a series of clinical trials that are required and regulated by the U.S. Food and Drug Administration (FDA). FDA approval is a mandatory obligation for all military products placed into the hands of medical providers or service members for human use. Development priority is based upon four major factors: (1) the extent of the disease within the Combatant Commands' theater of operations, (2) the clinical severity of the disease, (3) the technical maturity of the proposed solution, and (4) the affordability of the solution (development, production, and sustainment). Malaria, dysentery, hepatitis , and Dengue diseases (a severe debilitating disease transmitted by mosquitoes), which are found in Africa Command, Central Command, European Command, Southern Command, and Pacific Command areas are at the top of the infectious diseases requirements list.
Document Details
- Document Type
- Project
- Publication Date
- Oct 01, 2017
- Source ID
- 849_0604807A_5_2040_PB_2017
Related Documents
- Root: Medical Materiel/Medical Biological Defense Equipment - Eng Dev
- Child Accomplishment: Infectious Disease Drug and Vaccine Engineering Development
- Child Cost Item: eef6738075a78e829cd7f70359afacde
- Child Cost Item: 3c2bd11892d6e584004a381ccac266e0
- Child Cost Item: e817509af5738b5e6c50032fd635d93c
- Child Cost Item: e4d923f28eb1bb3613171eecc5a2d769
- Child Cost Item: 7635d7d4733ec80ba7ddb4602a8cdd2a
- Child Cost Item: b790c24843d87a1f6fbec9f0360d8c65
- Child Cost Item: 92ad8b1a090133df38f284b1795b0e94
- Child Cost Item: 9eb7ea9b9513fb0d19c2949be182ad37
- Child Cost Item: 5790227aeeddc725c113514bab6e41c3
- Child Cost Item: 7cd94de44aec32dc1424c1c3da002961
- Child Cost Item: 19013f83000186fe814753a035a0f8c4
- Child Cost Item: 383f8f0bb2b505a594c56316b6a1878b
- Child Cost Item: 36d16ab6932415bbc401e37d27de369a